We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type |
---|---|---|---|
Bioanalytical Systems Inc | NASDAQ:BASI | NASDAQ | Common Stock |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 16.44 | 15.65 | 16.65 | 0 | 01:00:00 |
“The website expresses our bold new brand and Inotiv’s philosophy, expect more,” said Company President and Chief Executive Officer Robert Leasure, Jr. “It reflects our fundamental goal: Deliver excellent client experiences.”
Over the past year, the Company has worked hard and invested in program management and processes to coordinate teams and services at all of the Company’s sites, moving from a collective of broad responsibilities to more focused teams that are integrated and aligned with key client and internal needs.
We believe the brand presents a comprehensive portfolio of complementary resources and capabilities that enable the timely delivery of focused, actionable insights that help drug developers succeed in today’s competitive market.
Visit the new Inotiv website at inotivco.com.
About the Company
Bioanalytical Systems, Inc., operating as Inotiv, is a pharmaceutical development company providing contract research services and monitoring instruments to emerging pharmaceutical companies and the world's leading drug development companies and medical research organizations. The Company focuses on developing innovative services supporting its clients’ discovery and development objectives for improved decision-making and accelerated goal attainment. The Company’s products focus on increasing efficiency, improving data, and reducing the cost of taking new drugs to market. Visit inotivco.com for more information about the Company.
This release may contain forward-looking statements that are subject to risks and uncertainties including, but not limited to, risks and uncertainties related to changes in the market and demand for our products and services, the development, marketing and sales of products and services, changes in technology, industry and regulatory standards, the timing of acquisitions and the successful closing, integration and business and financial impact thereof, and various market and operating risks, including those detailed in the Company's filings with the U.S. Securities and Exchange Commission.
Company Contact:Jill C. BlumhoffChief Financial OfficerPhone: 765.497.8381jblumhoff@inotivco.com
1 Year Bioanalytical Systems Chart |
1 Month Bioanalytical Systems Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions